Top Markets
Coin of the day
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Clasificación en acciones #40984
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Precio por acción
$0.14627542
Capitalización bursátil
$56.32K
Cambio (1 día)
7.50%
Cambio (1 año)
2.59%
País
VG
Comercio CRISM Therapeutics Corporation (CRTX)

Categoría

Ratio P/S de CRISM Therapeutics Corporation (CRTX)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de CRISM Therapeutics Corporation, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de CRISM Therapeutics Corporation desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE